Shares of Aarti Drugs rallied 10 per cent on Friday to a new all-time high of Rs 1,299.50 on the BSE on expectation of good growth from its API (Active Pharmaceutical Ingredient) and formulation business.
In the past three months, the stock has zoomed 166 per cent, as compared to 17 per cent rise in the S&P BSE Sensex. At 11:24 am, it was up 7 per cent at Rs 1,262, against 0.6 per cent gain in the benchmark index.
For the January-March quarter (Q4FY20), Aarti Drugs' net profit more-than-doubled on a year-on-year basis to Rs 58.90 crore,
In the past three months, the stock has zoomed 166 per cent, as compared to 17 per cent rise in the S&P BSE Sensex. At 11:24 am, it was up 7 per cent at Rs 1,262, against 0.6 per cent gain in the benchmark index.
For the January-March quarter (Q4FY20), Aarti Drugs' net profit more-than-doubled on a year-on-year basis to Rs 58.90 crore,